{"title":"Ancillaries \u0026 Hormonal Support","description":null,"products":[{"product_id":"tamox-20","title":"Tamox 20","description":"\u003ch3\u003e\u003cstrong\u003e\u003cspan\u003eTamox – Tamoxifen Citrate 20mg\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eTamox is presented in the ORYVION catalog as a tablet formulation containing tamoxifen citrate, with a declared strength of 20mg per tablet, supplied in containers of 50 tablets. Tamoxifen is an orally active, nonsteroidal selective estrogen receptor modulator (SERM).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts pharmacological profile involves binding to estrogen receptors, blocking estrogen’s effects in some tissues while producing estrogen-like effects in others. In breast tissue, this action can inhibit the growth of estrogen-sensitive cancer cells. Its established medical applications include the treatment of certain breast cancers and breast cancer risk reduction in selected patients.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct Specifications:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCommercial name: Tamox\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eListed compound: Tamoxifen Citrate\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eDeclared strength: 20mg per tablet\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eFormat: Tablets\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003ePackage contents: 50 tablets\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant Note:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eTamoxifen can increase the risk of blood clots, including deep-vein thrombosis and pulmonary embolism. Serious risks also include stroke and uterine malignancies in patients with a uterus. Other adverse effects include hot flashes, menstrual disturbances, and cataracts.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003cdiv style=\"font-size: 10px; color: #666; line-height: 1.5; margin-top: 20px;\"\u003e\n\u003cstrong\u003eLegal Disclaimer\u003c\/strong\u003e\u003cbr\u003eAll products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.\u003cbr\u003e\u003cbr\u003eORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.\u003cbr\u003e\u003cbr\u003eBy purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.\u003cbr\u003e\u003cbr\u003eORYVION complies with relevant provisions under \u003cmeta charset=\"utf-8\"\u003eEU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.\u003c\/div\u003e","brand":"Orals","offers":[{"title":"Default Title","offer_id":67599212380309,"sku":null,"price":0.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/9241\/7173\/files\/ov-tamox.png?v=1790738788"},{"product_id":"exemestane-25","title":"Aromidex 25","description":"\u003ch3\u003e\u003cstrong\u003e\u003cspan\u003eAromidex – Exemestane 25mg\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAromidex is presented in the ORYVION catalog as a tablet formulation containing 25mg of exemestane per tablet, supplied in containers of 50 tablets. Exemestane is an orally active steroidal aromatase inhibitor that reduces estrogen production.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts mechanism of action involves irreversible inactivation of aromatase, the enzyme responsible for converting androgens into estrogens. This reduces estrogen availability rather than directly blocking estrogen receptors. Its established medical applications include the treatment of certain hormone-sensitive breast cancers in postmenopausal women.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct Specifications:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCommercial name: Aromidex\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eListed compound: Exemestane\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eDeclared strength: 25mg per tablet\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eFormat: Tablets\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003ePackage contents: 50 tablets\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant Note:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eExemestane can reduce bone mineral density over time, increasing the risk of osteoporosis and fractures. Common adverse effects include hot flashes, joint pain, fatigue, and increased sweating. It can cause fetal harm and should not be used during pregnancy.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003cdiv style=\"font-size: 10px; color: #666; line-height: 1.5; margin-top: 20px;\"\u003e\n\u003cstrong\u003eLegal Disclaimer\u003c\/strong\u003e\u003cbr\u003eAll products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.\u003cbr\u003e\u003cbr\u003eORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.\u003cbr\u003e\u003cbr\u003eBy purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.\u003cbr\u003e\u003cbr\u003eORYVION complies with relevant provisions under \u003cmeta charset=\"utf-8\"\u003eEU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.\u003c\/div\u003e","brand":"Orals","offers":[{"title":"Default Title","offer_id":67604430880917,"sku":null,"price":0.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/9241\/7173\/files\/OV-Aromidex.png?v=1790771609"},{"product_id":"anastroz-1","title":"Anastroz 1","description":"\u003ch3 data-pm-slice=\"1 1 []\"\u003e\u003cstrong\u003e\u003cspan\u003eAnastroz – Anastrozole 1mg\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAnastroz is presented in the ORYVION catalog as a tablet formulation containing 1mg of anastrozole per tablet, supplied in containers of 50 tablets. Anastrozole is an orally active, nonsteroidal aromatase inhibitor that reduces estrogen production.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts mechanism of action involves reversible inhibition of aromatase, the enzyme responsible for converting androgens into estrogens. By reducing estrogen availability, anastrozole can slow the growth of estrogen-dependent breast cancer cells. Its established medical applications include the treatment of certain breast cancers in postmenopausal women.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct Specifications:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCommercial name: Anastroz\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eListed compound: Anastrozole\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eDeclared strength: 1mg per tablet\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eFormat: Tablets\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003ePackage contents: 50 tablets\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant Note:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eAnastrozole can reduce bone mineral density, increasing the risk of osteoporosis and fractures, and may raise cholesterol levels. Common adverse effects include joint pain, hot flashes, weakness, and nausea. In women with pre-existing ischemic heart disease, more ischemic cardiovascular events were observed with anastrozole than with tamoxifen. Anastrozole can cause fetal harm and should not be used during pregnancy.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003cdiv style=\"font-size: 10px; color: #666; line-height: 1.5; margin-top: 20px;\"\u003e\n\u003cstrong\u003eLegal Disclaimer\u003c\/strong\u003e\u003cbr\u003eAll products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.\u003cbr\u003e\u003cbr\u003eORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.\u003cbr\u003e\u003cbr\u003eBy purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.\u003cbr\u003e\u003cbr\u003eORYVION complies with relevant provisions under \u003cmeta charset=\"utf-8\"\u003eEU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.\u003c\/div\u003e","brand":"Orals","offers":[{"title":"Default Title","offer_id":67604433502357,"sku":null,"price":0.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/9241\/7173\/files\/Ov-anastroz.png?v=1790753503"},{"product_id":"cabergoline-25","title":"Caberol 25","description":"\u003ch3 data-pm-slice=\"1 1 []\"\u003e\u003cstrong\u003e\u003cspan\u003eCaberol – Cabergoline 0.25 mg\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eCaberol is presented in the ORYVION catalog as a tablet formulation containing 0.25 mg of cabergoline per tablet, supplied in containers of 50 tablets. Cabergoline is a long-acting, orally active dopamine receptor agonist derived from ergot.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts mechanism of action primarily involves stimulation of dopamine D2 receptors in the pituitary gland, reducing prolactin secretion. Its established medical applications include the treatment of hyperprolactinemic disorders, whether idiopathic or associated with pituitary adenomas.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct Specifications:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCommercial name: Caberol\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eListed compound: Cabergoline\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eDeclared strength: 0.25 mg per tablet\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eFormat: Tablets\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003ePackage contents: 50 tablets\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant Note:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCabergoline can cause heart valve disease and fibrotic complications affecting the heart, lungs, or retroperitoneal tissues. Other adverse effects include nausea, dizziness, low blood pressure upon standing, and impulse-control disorders or compulsive behaviors.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003cdiv style=\"font-size: 10px; color: #666; line-height: 1.5; margin-top: 20px;\"\u003e\n\u003cstrong\u003eLegal Disclaimer\u003c\/strong\u003e\u003cbr\u003eAll products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.\u003cbr\u003e\u003cbr\u003eORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.\u003cbr\u003e\u003cbr\u003eBy purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.\u003cbr\u003e\u003cbr\u003eORYVION complies with relevant provisions under \u003cmeta charset=\"utf-8\"\u003eEU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.\u003c\/div\u003e","brand":"Orals","offers":[{"title":"Default Title","offer_id":67604749058197,"sku":null,"price":0.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/9241\/7173\/files\/OV-Caberol.png?v=1790772103"},{"product_id":"finasteride-5","title":"Proxar 5","description":"\u003ch3\u003e\u003cstrong\u003e\u003cspan\u003eProxar – Finasteride 5 mg\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eProxar is presented in the ORYVION catalog as a tablet formulation containing 5 mg of finasteride per tablet, supplied in containers of 50 tablets. Finasteride is an orally active inhibitor of type II 5-alpha-reductase, the enzyme responsible for converting testosterone into dihydrotestosterone (DHT).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts pharmacological action reduces DHT concentrations in the blood and androgen-sensitive tissues. The established medical application of the 5 mg formulation is the treatment of benign prostatic hyperplasia in men with an enlarged prostate. By reducing DHT activity, finasteride can decrease prostate volume and improve associated urinary symptoms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eProduct Specifications:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eCommercial name: Proxar\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eListed compound: Finasteride\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eDeclared strength: 5 mg per tablet\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eFormat: Tablets\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003ePackage contents: 50 tablets\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant Note:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eFinasteride can cause decreased libido, erectile dysfunction, and ejaculation disorders. Sexual symptoms persisting after discontinuation have been reported. It also lowers prostate-specific antigen (PSA), which can affect interpretation of prostate screening results. Exposure during pregnancy can harm the development of a male fetus; pregnant individuals should not handle crushed or broken tablets.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003cdiv style=\"font-size: 10px; color: #666; line-height: 1.5; margin-top: 20px;\"\u003e\n\u003cstrong\u003eLegal Disclaimer\u003c\/strong\u003e\u003cbr\u003eAll products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.\u003cbr\u003e\u003cbr\u003eORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.\u003cbr\u003e\u003cbr\u003eBy purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.\u003cbr\u003e\u003cbr\u003eORYVION complies with relevant provisions under \u003cmeta charset=\"utf-8\"\u003eEU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.\u003c\/div\u003e","brand":"Orals","offers":[{"title":"Default Title","offer_id":67604973781141,"sku":null,"price":0.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/9241\/7173\/files\/OV-Proxar.png?v=1790771807"}],"url":"https:\/\/oryvion.org\/collections\/ancillaries-hormonal-support.oembed","provider":"Oryvion","version":"1.0","type":"link"}